CureVac N.V. (FRA:5CV)
Germany flag Germany · Delayed Price · Currency is EUR
3.870
-0.080 (-2.03%)
Jun 5, 2025, 6:47 PM CET

CureVac Statistics

Total Valuation

CureVac has a market cap or net worth of EUR 875.04 million. The enterprise value is 495.72 million.

Market Cap 875.04M
Enterprise Value 495.72M

Important Dates

The next estimated earnings date is Friday, August 15, 2025.

Earnings Date Aug 15, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 225.16M
Shares Outstanding n/a
Shares Change (YoY) +0.20%
Shares Change (QoQ) +0.31%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 125.70M

Valuation Ratios

The trailing PE ratio is 4.84.

PE Ratio 4.84
Forward PE n/a
PS Ratio 1.67
PB Ratio 1.35
P/TBV Ratio 1.41
P/FCF Ratio 5.94
P/OCF Ratio 5.57
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.13, with an EV/FCF ratio of 3.37.

EV / Earnings 2.74
EV / Sales 1.00
EV / EBITDA 2.13
EV / EBIT 2.29
EV / FCF 3.37

Financial Position

The company has a current ratio of 7.65, with a Debt / Equity ratio of 0.06.

Current Ratio 7.65
Quick Ratio 7.33
Debt / Equity 0.06
Debt / EBITDA 0.15
Debt / FCF 0.25
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 33.04% and return on invested capital (ROIC) is 24.37%.

Return on Equity (ROE) 33.04%
Return on Assets (ROA) 19.93%
Return on Invested Capital (ROIC) 24.37%
Return on Capital Employed (ROCE) 33.54%
Revenue Per Employee 579,314
Profits Per Employee 199,840
Employee Count 983
Asset Turnover 0.73
Inventory Turnover 4.85

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +3.82% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +3.82%
50-Day Moving Average 3.13
200-Day Moving Average 3.02
Relative Strength Index (RSI) 58.70
Average Volume (20 Days) 60,565

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 7.23

Income Statement

In the last 12 months, CureVac had revenue of EUR 523.70 million and earned 180.66 million in profits. Earnings per share was 0.80.

Revenue 523.70M
Gross Profit 458.88M
Operating Income 228.37M
Pretax Income 209.11M
Net Income 180.66M
EBITDA 240.86M
EBIT 228.37M
Earnings Per Share (EPS) 0.80
Full Income Statement

Balance Sheet

The company has 438.33 million in cash and 37.38 million in debt, giving a net cash position of 400.95 million.

Cash & Cash Equivalents 438.33M
Total Debt 37.38M
Net Cash 400.95M
Net Cash Per Share n/a
Equity (Book Value) 646.69M
Book Value Per Share 2.87
Working Capital 407.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 157.03 million and capital expenditures -9.73 million, giving a free cash flow of 147.31 million.

Operating Cash Flow 157.03M
Capital Expenditures -9.73M
Free Cash Flow 147.31M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 87.62%, with operating and profit margins of 43.61% and 34.50%.

Gross Margin 87.62%
Operating Margin 43.61%
Pretax Margin 39.93%
Profit Margin 34.50%
EBITDA Margin 45.99%
EBIT Margin 43.61%
FCF Margin 28.13%

Dividends & Yields

CureVac does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.20%
Shareholder Yield n/a
Earnings Yield 20.65%
FCF Yield 16.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CureVac has an Altman Z-Score of 3.87.

Altman Z-Score 3.87
Piotroski F-Score n/a